European Journal of Heart Failure

DECEMBER 20, 2023

Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.

Cardio Oncology 75

Cardio Oncology Cancer Certification Document 75

DAIC

FEBRUARY 28, 2024

The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors. “We

Risk Factors 105

Risk Factors Cancer Cardio Oncology Blood Pressure 105

Becker's Hospital Review - Cardiology

OCTOBER 17, 2024

The Heart Failure Society of America has released a scientific statement outlining its insights on the link between heart failure and cancer, the two leading causes of mortality and morbidity in the U.S. 15 in the Journal of Cardiac Failure. The statement was published Oct.

Cardio Oncology 52

Cardio Oncology Heart Failure Cancer 52

Frontiers in Cardiovascular Medicine

JANUARY 19, 2024

Background Cancer therapy-related cardiac dysfunction due to trastuzumab has been well-known for many years, and echocardiographic surveillance is recommended every 3 months in patients undergoing trastuzumab treatment, irrespective of the baseline cardiotoxicity risk. Results Twelve (10.9%) patients had asymptomatic CTRCD.

Cardio Oncology 64

Cardio Oncology Cancer Heart Failure Risk Factors 64

Open Heart

AUGUST 22, 2022

Objective Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Women with breast cancer who underwent initial surgery were included. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking. preoperative, 66.0%

Cardio Oncology 52

Cardio Oncology Cancer Heart Failure Risk Factors 52

Frontiers in Cardiovascular Medicine

JUNE 6, 2024

Cardio-oncology is a new field of interest in cardiology focusing on the detection and treatment of cardiovascular diseases, such as arrhythmias, myocarditis, and heart failure, as side-effects of chemotherapy and radiotherapy. Here, we report a patient with new-onset AVRT/AVNRT and lung cancer who underwent chemotherapy.

Tachycardia 40

Tachycardia Cancer Cardio Oncology Arrhythmia 40